Brightgene Bio-medical Technology Co (SHSE:688166) Forward Dividend Yield %: 0.05% (As of Jul. 11, 2026)


SHSE:688166 Brightgene Bio-medical Technology Co Ltd SHSE:688166
84 GF Score
Price ¥31.19
GF Value ¥38.49
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Brightgene Bio-medical Technology Co Forward Dividend Yield %?

Brightgene Bio-medical Technology Co SHSE:688166 +4.66% 84 Forward Dividend Yield % is 0.05% as of Jul. 11, 2026. GuruFocus rates SHSE:688166 with a GF Score™ of 84/100 and a GF Value™ of ¥38.49 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 148 Biotechnology companies, Brightgene Bio-medical Technology Co ranks worse than 100% on this metric.

As of today (2026-07-11), the Forward Annual Dividend Yield of Brightgene Bio-medical Technology Co is 0.05%.

As of today (2026-07-11), the Trailing Annual Dividend Yield of Brightgene Bio-medical Technology Co is 0.05%.

SHSE:688166's Forward Dividend Yield % is ranked worse than
100% of 148 companies
in the Biotechnology industry
Industry Median: 1.31 vs SHSE:688166: 0.05

Brightgene Bio-medical Technology Co's Dividends per Share for the three months ended in Mar. 2026 was ¥0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was -7.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.30% per year.

During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Brightgene Bio-medical Technology Co was 11.60% per year. The lowest was -7.20% per year. And the median was 4.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Brightgene Bio-medical Technology Co  (SHSE:688166) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Brightgene Bio-medical Technology Co Forward Dividend Yield % Related Terms


SHSE:688166 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Brightgene Bio-medical Technology Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brightgene Bio-medical Technology Co Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Brightgene Bio-medical Technology Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Brightgene Bio-medical Technology Co's Forward Dividend Yield % falls into.


SHSE:688166
84GF Score
Brightgene Bio-medical Technology Co Ltd SHSE:688166
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brightgene Bio-medical Technology Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Brightgene Bio-medical Technology Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.0160002026-06-092026-06-082026-06-09Cash DividendannuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Brightgene Bio-medical Technology Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.016/31.19
=0.05 %

Current Share Price is ¥31.19.
Brightgene Bio-medical Technology Co's Dividends per Share for the forward twelve months is calculated as ¥0.016 * 1 = ¥0.016.

Brightgene Bio-medical Technology Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.016/31.19
=0.05 %

Current Share Price is ¥31.19.
Brightgene Bio-medical Technology Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.016.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 0.05% mean?
Brightgene Bio-medical Technology Co (SHSE:688166) has a Forward Dividend Yield % of 0.05% as of Jul. 11, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Brightgene Bio-medical Technology Co and its competitors. According to the industry distribution chart, Brightgene Bio-medical Technology Co ranks #148 out of 148 companies in the Biotechnology industry.
Is Brightgene Bio-medical Technology Co's Forward Dividend Yield % too high?
Brightgene Bio-medical Technology Co's current Forward Dividend Yield % is 0.05%. The Biotechnology industry median Forward Dividend Yield % is 1.31. Brightgene Bio-medical Technology Co's value of 0.05% is 96.2% below this industry median. Based on the distribution chart, Brightgene Bio-medical Technology Co ranks #148 out of 148 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Brightgene Bio-medical Technology Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Brightgene Bio-medical Technology Co's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Brightgene Bio-medical Technology Co ranks #148 out of 148 companies for Forward Dividend Yield %. This places Brightgene Bio-medical Technology Co in the lower half of its industry. The industry median Forward Dividend Yield % is 1.31. Brightgene Bio-medical Technology Co's value of 0.05% is 96.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.31, based on 148 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Brightgene Bio-medical Technology Co's current Forward Dividend Yield % of 0.05% is 96.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Brightgene Bio-medical Technology Co and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Brightgene Bio-medical Technology Co's current Forward Dividend Yield % is 0.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brightgene Bio-medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co (SHSE:688166) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥38.49, compared to a current price of ¥31.19 — trading 19% below its estimated fair value. The current Forward Dividend Yield % is 0.05% and 96.2% below the Biotechnology industry median of 1.31. Brightgene Bio-medical Technology Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Brightgene Bio-medical Technology Co (SHSE:688166), the current Forward Dividend Yield % is 0.05% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Brightgene Bio-medical Technology Co (SHSE:688166) Overvalued in 2026?

Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co stock appears to be undervalued. The current stock price of ¥31.19 is trading 19% below its estimated GF Value™ of ¥38.49. GuruFocus considers Brightgene Bio-medical Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688166:

  • Forward Dividend Yield %: 0.05%
  • GF Value™: ¥38.49 vs. price of ¥31.19 (19% below fair value)
  • GF Score™: 84/100 with 7 warning signs
  • Industry Position: 96.2% below the Biotechnology median (#148 of 148)

No single metric tells the full story. See the SHSE:688166 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Brightgene Bio-medical Technology Co Business Description

Address No. 218 Xinghu Street, Buildings C25-C28, Nanotechnology Park, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215123
Brightgene Bio-medical Technology Co Ltd is engaged in the Research and development and production of pharmaceutical intermediates, active pharmaceutical ingredients and formulations with high technological barriers.
84GF Score

Get the complete analysis for SHSE:688166

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.19
Price
¥38.49
GF Value